TeleTrader 5/5 Merck completes acquisition of Terns
GlobeNewswire 5/4 INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lea...
GlobeNewswire 5/4 Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
GlobeNewswire 5/1 Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failu...
TeleTrader 4/30 US set to open higher amid earnings
GlobeNewswire 4/30 Immutep Quarterly Activities Report Q3 FY26
TeleTrader 4/30 Merck's Q1 sales beat estimates at $16.3B, up 5%
TMX Newsfile 4/29 Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failu...
GlobeNewswire 4/29 Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chi...
GlobeNewswire 4/29 Spherix Advances Oncology Leadership with Novel PD-1 Findings and Inaugural Presence at American Soc...
GlobeNewswire 4/29 INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lea...
GlobeNewswire 4/27 TOMI Environmental Solutions, Inc. Sees Strong Interest In Its Solutions at INTERPHEX 2026 
GlobeNewswire 4/27 Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain...
TeleTrader 4/24 US closes mostly higher, eyes US-Iran talks in Pakistan
GlobeNewswire 4/24 Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failu...
GlobeNewswire 4/23 Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failu...
GlobeNewswire 4/22 Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor
GlobeNewswire 4/22 Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
GlobeNewswire 4/22 Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ...
TeleTrader 4/21 US closes lower as Iran crisis reignites
GlobeNewswire 4/21 MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
GlobeNewswire 4/21 Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
GlobeNewswire 4/20 INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lea...
GlobeNewswire 4/20 Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combin...
GlobeNewswire 4/17 Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC mo...